Presenile Dementia - PowerPoint PPT Presentation

About This Presentation
Title:

Presenile Dementia

Description:

Presenile Dementia Mary Ellen Quiceno, M.D. Case #1 33 y.o. reported memory loss in 2000. In 2002, episodes of left-sided numbness & weakness. Febrile day prior to ... – PowerPoint PPT presentation

Number of Views:305
Avg rating:3.0/5.0
Slides: 69
Provided by: phdresCar
Category:

less

Transcript and Presenter's Notes

Title: Presenile Dementia


1
Presenile Dementia
  • Mary Ellen Quiceno, M.D.

2
Case 1
  • 33 y.o. reported memory loss in 2000.
  • In 2002, episodes of left-sided numbness
    weakness.
  • Febrile day prior to first admission in 2002 for
    h/a, n/v, and left-sided weakness.
  • Abnormal MRI and LP.
  • Progressively worsened and developed seizures,
    tremor, startle, and ataxia.
  • No family history.
  • Died a week after brain biopsy from pulmonary
    embolism. Biopsy nondiagnostic.

3
MRI/MRA brain, spine.
  • Subtle alteration of FLAIR signal in the basal
    ganglia bilaterally and subtle diffuse
    enhancement in the pons and thalami (nonspecific
    findings, ?occult vascular malformations?capillary
    telangiectasias).
  • No change on repeat brain scans done 12/02, 6/03.
    Developed atrophy.
  • Normal MRA.
  • C2 T2 hyperintensities (?myelomalacia or
    demyelinization).

4
Case 2
  • Mid-40s Caucasian man with degenerative
    dementia.
  • Institutionalized.
  • Parents deny history of dementia or psychiatric
    disturbances in family.
  • Taking Haldol.
  • Exam No chorea. Very disinhibited. Difficult to
    examine?repeatedly says I love you.

5
Case 2 Diagnosis
  • Once Haldol stopped, chorea was seen.
  • Family finally disclosed that patient was adopted
    and HIS family history was unknown.
  • Tested positive for Huntingtons disease.

6
Presenile Dementia
7
Presenile Dementia
  • Rare lt40 years old.
  • Overall prevalence of presenile dementias in the
    45 to 65 year old age group 15-80/100,000.

8
Presenile Dementia
  • Age of onset and premorbid functioning.
  • lt65 y.o.
  • Psychiatric history? Education? Level of
    functioning?
  • Family history.
  • Clinical characteristics.
  • Neurological dysfunction.
  • Other diseases or dysfunction (medical,
    psychiatric).

9
Expected Age-related Cognitive Changes
  • Bradyphrenia.
  • Trouble with recall of names of people/places.
  • Decreased concentration.
  • Language, vocabulary spared and may improve.

10
Why Age of Onset Matters
  • Metabolic genetic very early.
  • Can have later onset of some metabolic d/o.
  • Anticipation with triplicate disorders.
  • Differential differs between presenile and senile
    dementias.
  • Some disorders have more predictable onset.

11
Temporal Course of Disease
  • Slowly or rapidly progressive?
  • Gradual and insidious, stepwise, fluctuating,
    acute onset then static?

12
Cognitive Profile
  • Onset with memory, frontal executive dysfunction,
    other
  • Cortical.
  • Language, memory, praxis.
  • AD, FTD.
  • Frontal-subcortical.
  • Slow, poor attention, decreased verbal output,
    apathy.
  • Other dementias.
  • Mixed.

13
Associated FeaturesBehavioral Neurological
  • Personality behavior changes.
  • Depression psychosis.
  • Seizures.
  • Myoclonus.
  • Ataxia.
  • Tremor.
  • Parkinsonism.

14
Differential Diagnosis
15
Differential Diagnoses
  • Neurodegenerative disorders.
  • SCA, HD, DRPLA, Alzheimers disease, FTD, DLB
    related dementias.
  • Vascular.
  • Infectious.
  • Syphilis, CJD, vCJD, HIV-related.
  • Tumor Paraneoplastic disease.
  • Anti-Yo.
  • Autoimmune Inflammatory.
  • MS, sarcoid.
  • Trauma.
  • Toxic Metabolic.

16
Inherited Dementias
  • AD
  • FTD
  • HD
  • SCA
  • Wilsons
  • Prion
  • CADASIL
  • Storage Disorders
  • Lysosomal
  • Niemann-Pick
  • MLD
  • Peroxisomal
  • ALD
  • Lafora Body Disease
  • Mitochondrial d/o

17
Rapidly Progressive Dementias
  • Reversible
  • NCSE
  • Drugs
  • Meningitis
  • Whipples
  • Tumor
  • Irreversible
  • CJD
  • Rapidly progressive variants of AD

18
Dementia-Plus Syndromes
  • Cognitive impairment in the setting of more
    wide-spread neurological disturbance.
  • Ataxia HD, DRPLA, Wilsons, SCA, Prion
  • EPS FTDP-17, HD, Wilsons
  • Psychiatric FTD, HD, Wilsons

19
More Common Dementias
20
Most CommonSenile Presenile Dementias
  • SENILE
  • Alzheimers ds. 70-80?
  • Lewy Body ds.
  • Vascular ds.
  • FTD.
  • Other.
  • PRESENILE
  • Alzheimers ds 30
  • Vascular ds 15
  • FTD 13
  • LBD 4
  • Other 25
  • HD, MS, CBGD, Prion disease, PD.

21
Alzheimers disease
  • May manifest in 4th decade.
  • Autosomal dominant with complete penetrance.
  • Presenilin 1 on chromosome 14.
  • APP on chr. 21 (Downs), PS-2 on chr. 1
  • Creates abnormally aggregated b-amyloid

22
Neuropathology the same in Presenile and Senile
Onset AD
  • Neuritic plaques
  • extracellular
  • b-amyloid
  • Neurofibrillary tangles
  • intracellular
  • tau protein
  • Basal forebrain nuclei
  • leads to Ach deficit

23
Clinically Similar
  • Early involvement of medial temporal lobe.
  • hippocampus and entorhinal cortex
  • Parietal lobe dysfunction.
  • Myoclonus may be more prominent in familiar
    forms.
  • Naming may be spared until late in familiar forms.

24
Frontotemporal Lobar Degenerations (FTLD)
  • Onset 20-75 years of age.
  • Male predominance.
  • Half have family history (may be heterogeneous).
  • Various genetic mutations known.
  • Chr. 17 tau gene mutation most common.
  • FTD with parkinsonism.
  • Clinically variable within families.

25
FTLD types
  • Picks disease.
  • 3 repeat tau isoform aggregates
  • FTD behavioral, PPA, SD.
  • CBGD.
  • FTD associated with MND.
  • Ubiquitin positive, tau negative inclusions

26
FTD
  • Behavioral Onset
  • First attributed to depression, referred to
    psychiatrist.
  • Personality change, blunted affect, loss of
    motivation.
  • Frontal atrophy on MRI (may be missed).
  • Semantic Dementia
  • Progressive fluent aphasia.
  • Mistaken for AD.
  • Progressive Aphasia
  • Non-fluent aphasia.
  • Paraphasic errors.
  • Orofacial apraxia.

27
FTD
28
Vascular Dementia
  • Usual risk factors, plus unusual cardiac,
    hematological, metabolic, and genetic causes.
  • CADASIL (cerebral autosomal dominant arteriopathy
    with subcortical infracts and leukoencephalopathy)
    .
  • Mean age of presentation in 50-60s.
  • Can present in 20s with migraines w/aura and MRI
    changes.
  • Consider MRI in migraineurs w/ atypical auras,
    family hx.
  • Chr. 19 mutation on Notch 3 gene

29
CADASIL
  • Cerebral non-atherosclerotic, nonamyloid
    angiopathy of white matter and basal ganglia
  • Stroke 84, dementia 80, migraine with aura or
    mood disorders in 20
  • Slow stepwise deterioration of cognitive and
    neurological function
  • Frontal dysfunction, pseudobulbar palsy, gait
    problems, incontinence

30
MRI in 2 patients with CADASIL
  • The top MRIs are from a 30 year-old with migraine
    w/aura and CADASIL
  • The bottom MRIs are from a 57 year-old with
    migraine, stroke, and dementia.

31
Lewy Body Dementia
  • Rare in presenile populations.
  • Dementia.
  • Fluctuating cognitive impairment or
    consciousness.
  • Visual hallucinations.
  • Parkinsonism.
  • Neuritic plaques and Lewy bodies
  • a-synuclein inclusions

32
Transmissible Spongiform Encephalopathies (Prion)
  • Diffuse brain spongiosis.
  • Deposition of abnormal PrP (prion protein).
  • 90 sporadic, others acquired or inherited.
  • Post-translational conversion of the native prion
    protein in sporadic forms, causing accumulation
    in neurons.
  • Mutations to PRNP gene on chr. 20 in inherited
    cases.

33
Sporadic Inherited Prion D/Os
  • CJD incidence 1/1,000,000(?)
  • nvCJD BSE
  • Genetic susceptibility in 40 of UK residents
  • Rapid dementia in 60s w/death lt6 mo.
  • Insomnia, amotivation, myoclonus, ataxia,
    cortical blindness.
  • Familial CJD
  • similar to sporadic
  • Fatal Familial Insomnia
  • insomnia dysautonomia
  • Gerstmann-Straussler-Scheinker syndrome
  • ataxia, dementia

34
Hyperintensity in the basal ganglia and cortical
ribboning are distinct imaging features of
sporadic CJD.
35
MRI differences in CJD, nvCJD
  • MRI of nvCJD patients is associated with
    hyperintensity of the pulvinar (posterior nuclei)
    of the thalamus
  • MRI of sporadic CJD is associated with high
    signal changes in the putamen and caudate head.

36
Summary
  • Alzheimers disease
  • Vascular dementia
  • FTLD
  • Prion disorders

37
Less Common Dementias
38
Wilsons Disease
  • Autosomal recessive disorder of copper transport
  • Prevalence of 1/50,000 in UK.
  • Tremor, dystonia, chorea, ataxia, dysarthria,
    psychiatric cognitive changes.
  • Low serum copper and ceruloplasim levels with
    increased 24o urinary Cu excretion.

39
Huntingtons Disease
  • Family history may NOT be known.
  • Suicide, institutionalization.
  • Chorea may be suppressed by antipsychotics used
    by psychiatrist.
  • Trinucleotide repeat (CAG) gt35 on chr. 4
  • AD with complete penetrance.
  • Sporadic mutations rare.
  • 25,000 affected in US. 10/100,000 prev.
  • Caudate atrophy seen on MRI.

40
Huntingtons Disease
41
Whipples Disease
  • Caused by bacteria Tropheryma whippelii
  • Classic clinical features
  • chronic diarrhea with malabsorption, abdominal
    pain, relapsing-remitting migratory
    polyarthralgia, lymphadenopathy, weight loss,
    hyperpigmentation of the skin, and fever of
    unknown origin.
  • CNS may be affected in 40.
  • Neurological presentation is rare (5) and is
    often followed by disease confined to the CNS.

42
Neuropathology of CNS Whipples Disease
  • Disseminated or focal macrophagic encephalitis or
    meningoencephalitis favoring subpial and
    subependymal grey matter.
  • Mass lesions and obstructive hydrocephalus can be
    found.
  • Infarcts are also described.
  • secondary to surrounding chronic inflammation or
    to a primary vasculitic process

43
Symptoms of CNS Whipples Ds
  • Cognitive changes (71),
  • Supranuclear gaze palsy,
  • Altered consciousness are the commonest
    neurological findings.
  • Oculomasticatory (OMM) and oculofacial skeletal
    myorhythmia (OFSM),
  • Myoclonus,
  • Ataxia,
  • Hypothalamic dysfunction,
  • Cranial nerve abnormalities,
  • UMN dysfunction,
  • Sensory deficits.

44
Myorhythmia
  • Pathognomonic for Whipple's disease
  • Oculomasticatory Slow, smooth convergent-divergen
    t pendular nystagmus associated with synchronous
    contractions of the jaw.
  • Oculo-facial-skeletal nystagmus plus synchronous
    contractions of other body parts.
  • Occur in 20 and are always associated with a
    supranuclear vertical gaze palsy.

45
Guidelines for the diagnosis ofCNS Whipples
Disease
  • Definite diagnosis
  • presence of OMM or OFSM or a positive biopsy or
    positive PCR analysis.
  • Neurological signs are required when the positive
    results have been obtained from non-CNS tissue.

46
CNS Whipples Disease
  • The majority of intestinal (70), brain (83),
    lymph node and vitreous fluid biopsies (89)
    performed are diagnostic.
  • Electron microscopy
  • T whippelii DNA is found in normals.
  • The analysis of preferably more than one tissue
    substrate have been advised to maximize
    sensitivity and specificity.
  • PCR may also be useful to monitor response to
    treatment and prognosis.

47
Testing for Whipples
  • PCR in CSF can be negative in 20-30.
  • 80 with neurological symptoms and 70 of
    patients without neurological symptoms have
    yielded positive CSF PCR results in one series.
  • CSF PCR may be more sensitive in the presence of
    CSF pleocytosis.
  • ESR, CSF serum ACE concentrations may be
    elevated.

48
Treatment of Whipples Disease
  • Ceftriaxone 2 g IV3/day plus ampicillin 2 g
    IV 3/day for 14 days
  • Followed by oral TMP-SMX (160800 mg) twice daily
    for 1-2 years
  • Ceftriaxone 2g IV BID plus streptomycin 1 g/day
    for 14 days
  • Followed by oral TMP-SMX (160800 mg) twice daily
    for 1-2 years or cefixime 400 mg po qd for 1-2
    years

49
DRPLA (Dentatorubral-Pallidoluysian Atrophy)
  • Ataxia, choreoathetosis, dementia, and
    psychiatric disturbance.
  • Positive family hx (AD) and the detection of a
    CAG repeat (48-93) on chr. 12.
  • Significant anticipation 28 yrs/gen w/ paternal
    transmission and 15 yrs/gen w/ maternal
    transmission.
  • Age of onset is from 1 to 62 years with a mean
    age of onset of 30 years.

50
DRPLA
  • Described in Japanese and African American
    families.
  • Differential HD and SCA 1, 2, 3, 6, 7.
  • The history of ataxia as an early symptom as well
    as atrophy of the cerebellum and brainstem
    (particularly pontine tegmentum) on imaging study
    is important in the differential diagnosis.

51
Spinocerebellar Ataxias (SCA)
  • Slowly progressive incoordination of gait and
    often associated with poor coordination of hands,
    speech, and eye movements.
  • Atrophy of the cerebellum.
  • The hereditary ataxias are categorized by mode of
    inheritance, gene, or chromosome locus.

52
Spinocerebellar Ataxias
  • 26 described.
  • Triplicate repeats in 1, 2, 3, 6, 7, 8, 10, 12,
    17.
  • Difficult to distinguish clinically.
  • Some have peripheral neuropathy, seizure,
    dementia associated
  • Genetic testing available for some SCAs.

53
World-wide Incidence of SCAs
54
SCA 3 or Machado-Joseph disease
  • The diagnosis of SCA3 is suggested in individuals
    with the following findings
  • Cerebellar ataxia and pyramidal signs (type II
    disease) associated in variable degree with a
    dystonic-rigid extrapyramidal syndrome (type I
    disease)
  • Or peripheral amyotrophy (type III disease)
  • Minor (but more specific) clinical signs such as
    progressive external ophthalmoplegia, dystonia,
    action-induced facial and lingual
    fasciculation-like movements, and bulging eyes
  • Autosomal dominant inheritance

55
Differential Diagnosis of Ataxias
  • ataxia-telangiectasia,
  • alcoholism,
  • vitamin deficiency (E),
  • Friedreichs ataxia,
  • multiple sclerosis,
  • vascular disease,
  • primary or metastatic tumors,
  • or paraneoplastic diseases associated with occult
    carcinoma of the ovary, breast, or lung.

56
Paraneoplastic Limbic Encephalitis (PLE)
  • Represents an autoimmune response to tumor
    antigens
  • Predominantly Neuronal nuclear (Anti-Hu) ab (50
    of cases)
  • Lymphocytic infiltrate in CNS
  • Can precede cancer diagnosis
  • small cell lung cancer (80), testicular, breast
  • Symptoms usually progress over the course of
    weeks to months, reaching a plateau of neurologic
    disability.

57
Symptoms of PLE
  • Memory loss, personality changes, anxiety or
    depression, neuropsychiatric disturbances,
    partial or generalized seizures, olfactory and
    gustatory hallucinations, sleep disturbances, and
    abnormalities in other homeostatic functions.
  • Focal neurologic disturbances such as aphasia,
    weakness, or numbness.
  • Brainstem encephalitis
  • Autonomic dysfunction in 1/4.
  • Motor neuron dysfunction.
  • Lambert-Eaton myasthenic syndrome occurs in
    10-16 of cases.

58
Symptoms of PLE
  • Subacute Sensory Neuronopathy
  • Seen in 70-80 of cases.
  • Symptoms include
  • asymmetric focal numbness or paresthesias,
    typically involving the face, trunk, and proximal
    extremities.
  • burning or lancinating dysesthesias of all
    extremities may be noted at later stages.

59
Diagnosis of PLE
  • Serum and CSF paraneoplastic antibody panel
  • Anti-Hu or other PEM antibodies (anti-CV2,
    anti-Yo, anti-Ma1, anti-Ta or anti-Ma2) may be
    found.
  • Cerebrospinal fluid
  • Cell count, protein, glucose, oligoclonal bands,
    IgG synthesis rate, cytology, and PCR for herpes
    simplex virus and varicella zoster virus
  • Evaluate for an underlying malignancy Serum
    tumor markers
  • Brain MRI may help to rule out the differential
    diagnoses. Usually, MRI in a patient with PEM is
    unremarkable, although T2-weighted hyperintensity
    may be noted in mesial temporal lobes and
    associated limbic structures.

60
Mesial temporal hyperintensity demonstrated on
T2-weighted (left) and fluid-attenuated inversion
recovery (FLAIR, right) MRI
61
Treatment of Paraneoplastic Limbic Encephalitis
  • Plasmapheresis
  • IVIG
  • Steroids or Cytoxan
  • Monitor for cancer

62
Steroid-responsive Encephalopathies
  • Heterogeneous group of disorders
  • May represent underlying cerebral vasculitis
  • Circulating autoantibodies
  • Hashimotos Encephalopathy

63
Hashimotos Encephalopathy
  • Seizures, stroke-like events, temporary
    neurologic deficits, and a variety of psychiatric
    disturbances from dementia to visual
    hallucinations and frank psychosis.
  • Significantly elevated antithyroid antibody
    titers, mainly anti-thyroid peroxidase (TPO)
    antibodies.
  • Pathogenetic hypotheses proposed so far
  • excessive thyrotropin-releasing hormone output,
  • edema-induced cerebral dysfunction,
  • global hypoperfusion,
  • an autoimmune-mediated inflammatory attack of
    cerebral vessels.

64
Approach to Diagnosis of Presenile Dementia
65
Approach to Diagnosis
  • Observation
  • History from family
  • Explore different cognitive domains impact on
    daily functioning
  • Psychiatric history
  • Family history
  • Physical and neuropsychological exams

66
Investigations for Determination of Diagnosis and
Recognition of Treatable Disorders
  • EEG
  • MRI brain
  • Possible LP
  • Possible brain or tissue biopsy
  • CADASIL, vasculitis, Whipples, CJD
  • Other...
  • Blood Urine testing
  • Drug screen
  • TSH, B12, ?ESR
  • Syphilis
  • Vasculitides/CTD
  • HIV, heavy metals, Cu/ceruloplasm

67
Treatable Causes of Cognitive Impairment
  • Dont forget these
  • Obstructive Sleep Apnea
  • Depression
  • Drugs alcohol (thiamine deficiency,Li toxicity,
    BZD)
  • Epilepsy

68
Treatment
  • Accurate diagnosis extremely important
  • Supportive care for patient and family
  • Treat psychiatric symptoms
  • Acetylcholinesterase inhibitors and NMDA receptor
    antagonist
  • Anti-epileptics
Write a Comment
User Comments (0)
About PowerShow.com